Français Néerlandais Japonais Chinois Allemand Espagnol Portugais

Major innovation in fight against pleural cancer

05 Apr 2016 | Health Nutrition, A region on the move

Lille hospital plays a key role in new treatment for pleural cancer.

Healthcare innovation in Northern France

For over 10 years, medicine had made no progress in treating cancer of the pleura, the membrane lining the lungs.

But now the Bio-MAPS program, launched by Dr. Gérard Zalcman in close cooperation with 70 French hospital groups, has shown that Bevacizumab is effective in treating pleural cancer, significantly reducing mortality risk in 23% of patients who were treated with it.

Dr. Arnaud Scherpereel, head of pulmonology and thoracic oncology at Lille University Hospital Center (CHRU) and coordinator of the Bevacizumab project, stresses that the treatment is equally effective in all patient sub-groups, including those with the worst prognosis factors.

As a result, this new treatment solution is becoming the first-line therapy for patients with pleural cancer.

Back to news

News

Häagen-Dazs launches mini-bars

Häagen-Dazs is set to invest €14 billion to produce mini ice cream bars at its plant in Hauts-de-France, near Arras.

Prysmian Draka Filéca invests in Beauvais plant

The world leader in energy and telecom cables is investing €7 million at its site in Hauts-de-France to shift production of key raw materials in-house.

All news